Gosmanova, Elvira O. http://orcid.org/0000-0001-8392-8004
Houillier, Pascal http://orcid.org/0000-0003-4953-6917
Rejnmark, Lars http://orcid.org/0000-0002-2152-4247
Marelli, Claudio http://orcid.org/0000-0002-5783-1142
Bilezikian, John P. http://orcid.org/0000-0002-1570-2617
Funding for this research was provided by:
Shire International GmbH, a Takeda company, Zurich, Switzerland
Article History
Accepted: 3 November 2020
First Online: 18 February 2021
Compliance with ethical standards
:
: E. Gosmanova has served as a consultant for Shire, a Takeda company; P. Houillier has served as an advisory board member, speaker, and research investigator for Shire, a Takeda company; C. Marelli is an employee of Takeda Pharmaceuticals International AG, Zurich, Switzerland; L. Rejnmark has served as a consultant and speaker for Shire, a Takeda company; J. Bilezikian has served as an advisory committee/board member, received consulting fees and grant/research support, and acted as speaker for Shire, a Takeda company.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.